TLR9 and Hepatitis: In summary, we show that type I and II IFN-induced STAT1 activation drives TLR9-associated features, particularly liver inflammation, which is characterized by IFN-γ-producing cycling T cells, cDC2s, and monocytes transitioning into inflammatory Mφs.